Solventum Corp (SOLV)
- Sector
- Health Care
- Industry
- Health Care Technology
- Last price
- $86.30
- As of
Kresmion compiles this page from SOLV's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Solventum Corp (SOLV): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-05.
See the full SOLV dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SOLV on one page. Preview it with sample data, then open it live with a free account.
Preview the SOLV dossierActive signals for SOLV
- highCONSENSUS_BUY
5 tracked funds increased SOLV this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 89% of SOLV (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +192% to SOLV (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +206% to SOLV (2026Q2)
- highCONSENSUS_BUY
4 tracked funds increased SOLV this 2026Q2, institutional consensus
FREE, NO ACCOUNT
Every signal on SOLV, as it fires
You are seeing 5 of 27 signals recorded on SOLV since 2026-05-02.
The five above landed across 2 days. The other 22 were recorded on 5 other days. 20 of the 27 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SOLV (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 83444M101 · 2026Q2 | $92.6M | 0.03% | , |
| D. E. Shaw & Co., Inc.CUSIP 83444M101 · 2026Q2 | $40.6M | 0.02% | , |
| Bridgewater Associates, LPCUSIP 83444M101 · 2026Q2 | $13.7M | 0.06% | , |
| Point72 Asset Management, L.P.CUSIP 83444M101 · 2026Q2 | $7.9M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 83444M101 · 2026Q2 | $7.6M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 83444M101 · 2026Q2 | $265K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SOLV
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SOLV against its peers
SOLV's operating margin of 26.2% ranks in the 97th percentile of 16 Health Care sector peers, fiscal periods ending between 2025-10-31 and 2026-05-31.
| Metric | SOLV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 8.3B USD | 3.9B USD | 63 | 19 |
| Gross margin | 53.5% | 54.6% | 45 | 9 |
| Operating margin | 26.2% | 1.9% | 97 | 16 |
| Net margin | 18.7% | -0.0% | 88 | 19 |
| Return on equity | 30.8% | 3.3% | 79 | 16 |
| P / E | 9.7x | 26.5x | 5 | 9 |
| 1 year | 21.8% | 15.7% | 57 | 19 |
Peers (19): A, ABBV, ABT, ACH, ACHC, AHCO, ALGN, ALHC, AMGN, AMN, ANGO, ATEC, ATRC, AVAH, BAX, BIIB, BKD, BMY, BSX. Left out: BDX (no annual filing). Fiscal periods ending between 2025-10-31 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (SOLV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow SOLV on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to SOLV for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.